125 related articles for article (PubMed ID: 26298328)
1. Psychotic syndrome associated with anti-Ca/ARHGAP26 and voltage-gated potassium channel antibodies.
Jarius S; Wildemann B; Stöcker W; Moser A; Wandinger KP
J Neuroimmunol; 2015 Sep; 286():79-82. PubMed ID: 26298328
[TBL] [Abstract][Full Text] [Related]
2. Anti-Ca/anti-ARHGAP26 antibodies associated with cerebellar atrophy and cognitive decline.
Doss S; Nümann A; Ziegler A; Siebert E; Borowski K; Stöcker W; Prüss H; Wildemann B; Endres M; Jarius S
J Neuroimmunol; 2014 Feb; 267(1-2):102-4. PubMed ID: 24439423
[TBL] [Abstract][Full Text] [Related]
3. Rho GTPase-activating protein 10 (ARHGAP10/GRAF2) is a novel autoantibody target in patients with autoimmune encephalitis.
Jarius S; Komorowski L; Regula JU; Haas J; Brakopp S; Wildemann B
J Neurol; 2022 Oct; 269(10):5420-5430. PubMed ID: 35624318
[TBL] [Abstract][Full Text] [Related]
4. Two new cases of anti-Ca (anti-ARHGAP26/GRAF) autoantibody-associated cerebellar ataxia.
Jarius S; Martínez-García P; Hernandez AL; Brase JC; Borowski K; Regula JU; Meinck HM; Stöcker W; Wildemann B; Wandinger KP
J Neuroinflammation; 2013 Jan; 10():7. PubMed ID: 23320754
[TBL] [Abstract][Full Text] [Related]
5. From dizziness to severe ataxia and dysarthria: New cases of anti-Ca/ARHGAP26 autoantibody-associated cerebellar ataxia suggest a broad clinical spectrum.
Wallwitz U; Brock S; Schunck A; Wildemann B; Jarius S; Hoffmann F
J Neuroimmunol; 2017 Aug; 309():77-81. PubMed ID: 28601293
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies).
Bastiaansen AEM; van Sonderen A; Titulaer MJ
Curr Opin Neurol; 2017 Jun; 30(3):302-309. PubMed ID: 28248701
[TBL] [Abstract][Full Text] [Related]
7. Rho GTPase-activating protein 17 (ARHGAP17) as additional autoimmune target in ARHGAP26-IgG/anti-Ca autoantibody-associated autoimmune encephalitis.
Jarius S; Haas J; Wildemann B
J Neurol; 2023 Mar; 270(3):1776-1780. PubMed ID: 36333454
[No Abstract] [Full Text] [Related]
8. Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies.
Lang B; Makuch M; Moloney T; Dettmann I; Mindorf S; Probst C; Stoecker W; Buckley C; Newton CR; Leite MI; Maddison P; Komorowski L; Adcock J; Vincent A; Waters P; Irani SR
J Neurol Neurosurg Psychiatry; 2017 Apr; 88(4):353-361. PubMed ID: 28115470
[TBL] [Abstract][Full Text] [Related]
9. A new Purkinje cell antibody (anti-Ca) associated with subacute cerebellar ataxia: immunological characterization.
Jarius S; Wandinger KP; Horn S; Heuer H; Wildemann B
J Neuroinflammation; 2010 Mar; 7():21. PubMed ID: 20226058
[TBL] [Abstract][Full Text] [Related]
10. 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC.
Jarius S; Wildemann B
J Neuroinflammation; 2015 Sep; 12():167. PubMed ID: 26377184
[TBL] [Abstract][Full Text] [Related]
11. Voltage-gated potassium channel-complex autoimmunity and associated clinical syndromes.
Irani SR; Vincent A
Handb Clin Neurol; 2016; 133():185-97. PubMed ID: 27112678
[TBL] [Abstract][Full Text] [Related]
12. Expanding spectrum of contactin-associated protein 2 (CASPR2) autoimmunity-syndrome of parkinsonism and ataxia.
Kannoth S; Nambiar V; Gopinath S; Anandakuttan A; Mathai A; Rajan PK
Neurol Sci; 2018 Mar; 39(3):455-460. PubMed ID: 29264691
[TBL] [Abstract][Full Text] [Related]
13. Voltage-gated potassium channel/LGI1 antibody-associated encephalopathy may cause brief psychotic disorder.
van Elst LT; Klöppel S; Rauer S
J Clin Psychiatry; 2011 May; 72(5):722-3. PubMed ID: 21658353
[No Abstract] [Full Text] [Related]
14. The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis.
van Sonderen A; Petit-Pedrol M; Dalmau J; Titulaer MJ
Nat Rev Neurol; 2017 May; 13(5):290-301. PubMed ID: 28418022
[TBL] [Abstract][Full Text] [Related]
15. Detection of LGI1 and CASPR2 antibodies with a commercial cell-based assay in patients with very high VGKC-complex antibody levels.
Yeo T; Chen Z; Chai JYH; Tan K
J Neurol Sci; 2017 Jul; 378():85-90. PubMed ID: 28566186
[TBL] [Abstract][Full Text] [Related]
16. Anti-ARHGAP26 Autoantibodies Are Associated With Isolated Cognitive Impairment.
Bartels F; Prüss H; Finke C
Front Neurol; 2018; 9():656. PubMed ID: 30158896
[TBL] [Abstract][Full Text] [Related]
17. The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies.
van Sonderen A; Schreurs MW; de Bruijn MA; Boukhrissi S; Nagtzaam MM; Hulsenboom ES; Enting RH; Thijs RD; Wirtz PW; Sillevis Smitt PA; Titulaer MJ
Neurology; 2016 May; 86(18):1692-9. PubMed ID: 27037230
[TBL] [Abstract][Full Text] [Related]
18. Guillain-Barré-like syndrome: an uncommon feature of CASPR2 and LGI1 autoimmunity.
Tan X; Liu Y; Wu X; Guo Y
J Neurol; 2022 Nov; 269(11):5893-5900. PubMed ID: 35781606
[TBL] [Abstract][Full Text] [Related]
19. Presence of paraneoplastic antibodies in non-carcinomatous patients with neurological involvements of unknown cause.
Yanagihashi M; Kawabe K; Ikeda K
J Neurol Sci; 2013 Dec; 335(1-2):197-200. PubMed ID: 24094858
[TBL] [Abstract][Full Text] [Related]
20. Chronic Manganese Toxicity Associated with Voltage-Gated Potassium Channel Complex Antibodies in a Relapsing Neuropsychiatric Disorder.
Ho CSH; Ho RCM; Quek AML
Int J Environ Res Public Health; 2018 Apr; 15(4):. PubMed ID: 29669989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
